Which medications in the drug class Vaccines are used in the treatment of Haemophilus Meningitis?

Updated: Jul 09, 2018
  • Author: Prateek Lohia, MD, MHA; Chief Editor: Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM  more...
  • Print


Vaccines may be used in the prevention of Hib infection. Several studies in the United States and internationally have demonstrated a significant reduction in the incidence of invasive Hib infection soon after the introduction of the vaccine.

Haemophilus influenza type b vaccine (ActHIB, Hiberix, Liquid PedvaxHIB)

This vaccine is used for routine immunization of children against invasive diseases caused by Hib by decreasing nasopharyngeal colonization.

Hepatitis b vaccine/haemophilus influenzae type b vaccine (Comvax)

This conjugate Hib vaccine uses covalent binding of a capsular polysaccharide of Hib to the OMPC carrier to produce antigen postulated to convert T-independent antigen into T-dependent antigen, which enhances the antibody response and immunologic memory.

Diphtheria & tetanus toxoids/acellular pertussis vaccine/poliovirus vaccine inactivated/Haemophilus influenza type b vaccine (Pediarix)

This combination vaccine is used for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease caused by Hib in children aged 6 weeks to 4 years.

Meningococcal C and Y/haemophilus influenza type B vaccine (MenHibrix)

MenHibrix is a combination vaccine approved for use in children as young as 6 weeks old and is indicated to prevent invasive disease caused by Neisseria meningitides serogroups C and Y, and Haemophilus influenzae type b. MenHibrix was newly approved in 2012 and is a 4-dose sequence.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!